FDA asks how to improve existing Regulations
The U.S. Food and Drug Administration FDA announced that the agency is formally asking for submissions on how to improve existing regulations. FDA expects that retrospective reviews like this would help FDA focus on how to improve regulations.
- Where are regulations ineffective?
- Do regulations address current public health challenges?
- Is there a need to update regulations?
- Can regulations be revised in ways that make them less burdensome without making them less effective?
- Are there regulatory requirements that are redundant, inconsistent or needlessly overlap?
To get more information, go to the FDA Transparency Blog.
Related GMP News
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan